Angiotensin Receptor and Neprilysin Inhibitors for COVID-19 Treatment and Personalized Medicine?

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1089/omi.2022.0030

Angiotensin Receptor and Neprilysin Inhibitors for COVID-19 Treatment and Personalized Medicine?

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	318-319
Number of pages	2
Journal	Omics : a journal of integrative biology
Volume	26
Issue number	5
Early online date	27 Apr 2022
DOIs	https://doi.org/10.1089/omi.2022.0030
Publication status	Published - 11 May 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1089/omi.2022.0030Licence: Unspecified

Cite this

@article{9657931eb5e54ad08a71f72205be9b8c,

title = "Angiotensin Receptor and Neprilysin Inhibitors for COVID-19 Treatment and Personalized Medicine?",

keywords = "Angiotensin Receptor, Neprilysin Inhibitors, COVID-19",

author = "Kow, \{Chia Siang\} and Ramachandram, \{Dinesh Sangarran\} and Hasan, \{Syed Shahzad\}",

year = "2022",

month = may,

day = "11",

doi = "10.1089/omi.2022.0030",

language = "English",

volume = "26",

pages = "318--319",

journal = "Omics : a journal of integrative biology",

issn = "1536-2310",